期刊文献+

血脂异常与维持性血液透析患者脑卒中的相关性研究 被引量:2

Correlation between Dyslipidemia and Stroke in Patients undergoing Maintenance Hemodialysis
下载PDF
导出
摘要 【目的】探讨血脂异常与维持性血液透析(MHD)患者脑卒中的关系。【方法】选择MHD患者120例(观察组)与同期健康体检正常人员60例(对照组),依据脑卒中发生与否将观察组患者分为脑卒中组与非脑卒中组,比较各组血脂指标。【结果】观察组甘油三酯(TG)、低密度脂蛋白胆固醇(LDL—C)水平高于对照组,高密度脂蛋白胆固醇(HDL-c)低于对照组,差异有显著性(P〈0.05);脑卒中组TG、LDL-C水平分别为(2.76±0.94)mmol/L、(3.41±0.72)mmol/L,明显高于非脑卒中组的(1.68±0.79)mmol/L、(2.75±0.73)mmol/L,且差异均有显著性(P〈0.05),而HDL—C水平两组相当(0.93±0.30VS0.98±0.25)(P〉0.05);Lo—gistic多因素回归分析显示MHD患者脑卒中发生独立危险因素包括年龄、透析时间、透析前收缩压、TG、LDL—C水平。【结论IMHD患者年龄大、透析时间长、透析前收缩压、TG、LDL—C水平高是脑卒中发生的独立危险因素。 [Objective]To study the correlation between dyslipidemia and stroke in patients undergoing maintenance hemodialysis (MHD).[Methods]Atotal of 120 patients undergoing MHD (observation group) and 60 cases of healthy persons (control group) were enrolled in the study. According to the occurrence of stroke, the patients were divided into stroke group and non-stroke group. The blood lipids were compared a- mong groups.[Results]Levels of triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low- density lipoprotein cholesterol (LDL-C) showed significant differences between the observation group and the control group ( P %0.05). Levels of TG and LDL-C in stroke group were (2.76±0.94) mmol/L and (3.41± 0.72) mmol/L, respectively while those in the non-stroke group were (1.68±0.79) mmol/L and (2.75±0.73) mmol/L, respectively ( P〈0.05). Multivariate Logistic regression analysis showed that the independent risk factors for stroke in patients undergoing MHD included age, dialysis time, systolic blood pressure before dial- ysis, TG and LDL-C levels. [Conclusion]Dyslipidemia easily occur in patients undergoing MHD. Advanced age, long dialysis time, systolic blood pressure before dialysis, TG and LDL-C levels are the risk factors for the occurrence of stroke.
作者 何敬东
出处 《医学临床研究》 CAS 2017年第8期1489-1491,共3页 Journal of Clinical Research
关键词 血脂异常 肾透析 卒中 危险因素 Dyslipidemias Renal Dialysis Stroke Risk Factors
  • 相关文献

参考文献4

二级参考文献43

  • 1张韶君,龚凤英,邓洁英,朱惠娟,潘慧,张殿喜,李乃适.锌α_2糖蛋白真核表达载体的构建和体外表达鉴定[J].中国医学科学院学报,2010,32(3):283-288. 被引量:3
  • 2张怡玲,吴艳,栾桂君.透析患者脂质变化的临床意义[J].透析与人工器官,2005,16(1):1-3. 被引量:2
  • 3The Inter national Quotidian Dialysis Registry: annunal re- port 2005 [ R ]. Hemodial Int, 2005, 9 (3) : 203-209.
  • 4Weiner DE, Tighiouart H, Amin MG, et al. Chronic kid- ney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies[J]. Am Soc Nephrol, 2005, 15(5) : 1 307-315.
  • 5Agarwal R, Nissenson AR, Battle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodial- ysis patients in theUnited States [ J ]. Am J Med, 2003, 115(4) : 291-297.
  • 6LondonGM, PannierB, GuerinAP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study [ J ]. J Am Soc Nephrol, 2001, 12(12): 2 759-767.
  • 7Heerspink H J, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mor- tality in patients on dialysis: a systematic review andmeta- analysis of randomised controlled trials [ J ]. Lancet, 2009, 373(9 668) : 1 009-015.
  • 8Inrig JK, Patel UD, Gillespie BS, et al. Relationship be- tween interdialytic weight gain and blood pressure among prevalent hemodialysis patients [ J ]. Am J Kidney Dis, 2007, 50(1) : 108-118.
  • 9Attman PO, Samuelsson O, Alaupovic P. Lipoprotein me- tabolism in renal failure [ J ]. Am J Kidney Dis, 1993, 21 (6) : 573-592.
  • 10Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/ CRP evaluation (PRINCE): a randomized trial and cohort study[J]. JAMA, 2001,286(1) : 64-70.

共引文献36

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部